A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
Public ClinicalTrials.gov record NCT02409355. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Open-Label, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Compared With Gemcitabine+Cisplatin or Carboplatin for PD-L1-Selected, Chemotherapy Naive Patients With Stage IV Squamous Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, open-label study was designed to evaluate and compare the safety and efficacy of atezolizumab with gemcitabine + cisplatin or carboplatin in PD-L1 selected participants with chemotherapy-naive, Stage IV squamous NSCLC. The study was closed due to low patient enrollment and the Sponsor's decision to include patients with squamous NSCLC into the GO29431 study, NCT02409342. Therefore the planned objectives of this study are no longer applicable and formal analyses of efficacy or safety have not been performed.
Study identification
- NCT ID
- NCT02409355
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2015 (Actual)
- Primary completion
- Dec 7, 2017 (Actual)
- Completion
- Dec 7, 2017 (Actual)
- Last update posted
- Feb 15, 2019
2015 – 2017
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Associates for Research & Excellence, Inc. | Encinitas | California | 92008 | — |
| Marin Cancer Care Inc | Greenbrae | California | 94904 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| Chao Family Comprehensive Cancer Center; UC Irvine Medical Center | Orange | California | 92868 | — |
| Eastern Connecticut Hematology and Oncology Associates; (ECHO) | Norwich | Connecticut | 06360 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Florida Hospital | Orlando | Florida | 32803 | — |
| Straub Clinic & Hospital; Oncology | Honolulu | Hawaii | 96813 | — |
| Ingalls Memorial Hospital | Harvey | Illinois | 60426 | — |
| Consultants in Blood Disorders & Cancer | Louisville | Kentucky | 40207 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Bay Hematology Oncology | Easton | Maryland | 21601 | — |
| Montana Cancer Specialists | Missoula | Montana | 59802 | — |
| Atlantic Health Cancer Center | Summit | New Jersey | 07902 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Presbyterian Hospital | Charlotte | North Carolina | 28204 | — |
| Carolina Oncology Specialists, PA - Hickory | Hickory | North Carolina | 28602 | — |
| First Health of the Carolinas | Pinehurst | North Carolina | 28374 | — |
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Spartanburg Regional Medical Center | Spartanburg | South Carolina | 29303 | — |
| Wellmont Cancer Institute | Bristol | Tennessee | 37620 | — |
| University Oncology Associates | Chattanooga | Tennessee | 37403 | — |
| Sarah Cannon Cancer Center | Germantown | Tennessee | 38138 | — |
| Vanderbilt Medical Center | Nashville | Tennessee | 37232-7610 | — |
| MultiCare Regional Cancer Center - Auburn | Auburn | Washington | 98002-4117 | — |
| West Virginia University Hospital | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02409355, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 15, 2019 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02409355 live on ClinicalTrials.gov.